Introduction
============

Gene expression differences among species, including differences between humans and closely related primates, constitute one of the main sources of phenotypic and functional divergence ([@evw038-B19])

Recent advances in sequencing technology have allowed the investigation of expression-level evolution for different RNA types, including messenger RNA (mRNA), long noncoding RNA (lncRNA), and microRNA, which all show substantial evolutionary divergence among species, including humans ([@evw038-B4]; [@evw038-B31]; [@evw038-B32]).

A group of transcripts, mid-size RNA with length between 100 and 200 nt, have so far remained outside the scope of evolutionary transcriptomic studies. This length range mainly contains two noncoding RNA types: Small nuclear RNA (snRNA) and small nucleolar RNA (snoRNA). Both snRNAs and snoRNAs constitute conserved elements of basic posttranscriptional regulation machinery. In the human genome, there are ten snRNA gene families (*U1*, *U2*, *U4*, *U5*, *U6*, *U7*, *U4atac*, *U6atac*, *U11*, and *U12*), each represented by multiple copies. Functionally, all snRNAs, except *U7*, serve as essential elements of the spliceosome complexes ([@evw038-B30]).

SnoRNA are a more diverse type of transcripts, represented in the human genome by 1,740 genes, grouped into 226 families based on their Rfam classification ([@evw038-B5]). SnoRNAs function as part of ribo-protein complexes, guiding them to perform methylation or pseudouridylation at specific sites of ribosomal RNA (rRNA), transfer RNA, and snRNA ([@evw038-B24]; [@evw038-B9]; [@evw038-B15]; [@evw038-B23]). The target modification sites for approximately 80% of human snoRNAs can be predicted based on sequence complementarity ([@evw038-B27]); however, the remaining snoRNAs have no known targets. This suggests that the full spectrum of functional roles played by snoRNA remains to be determined. In support of this notion, some snoRNAs have recently been identified to play roles in the regulation of transcript processing and transcript stability ([@evw038-B20]; [@evw038-B8]; [@evw038-B21]; [@evw038-B3]; [@evw038-B39]).

Mechanisms of transcriptional regulation differ substantially for snRNAs and snoRNAs. Although snRNAs are transcribed from their own promoters, snoRNA, especially conserved snoRNA, do not commonly have independent promoter elements and are instead transcribed as a part of a larger transcript, commonly residing within an intron of mRNA or lncRNA ([@evw038-B13]).

Taken together, functional conservation, peculiarities of transcriptional regulation, as well as technical questions related to unusual RNA size range make snRNAs and snoRNAs an unconventional target for evolutionary studies. Here, by employing a size-fractionation procedure coupled with high-throughput sequencing, we nonetheless explored snRNAs and snoRNAs expression in the frontal cortex of four mammalian species: Humans, chimpanzees, rhesus monkeys, and mice. To our surprise, we show that expression of these transcripts has undergone a number of drastic changes on the primate and mouse lineages, including changes during the past 6--8 Myr of human evolutionary history.

Materials and Methods
=====================

Ethics Statement
----------------

This study was reviewed and approved by the Institutional Animal Care and Use ethics committee at the Shanghai Institutes for Biological Sciences.

Tissues and RNA Library Preparation
-----------------------------------

Human samples were obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland (USA). All subjects were defined as healthy controls by forensic pathologists at the corresponding tissue bank. Chimpanzee samples were obtained from the Anthropological Institute & Museum of the University of Zürich-Irchel (Switzerland), and the Biomedical Primate Research Centre (the Netherlands). Rhesus macaque samples were obtained from the Suzhou Experimental Animal Center (China). All nonhuman primates used in this study suffered sudden deaths for reasons other than their participation in this study and without any relation to the tissue used. Mouse samples were obtained from the mouse facility at Shanghai Institutes for Biological Sciences (China). All mouse individuals were from the C57BL/6 strain with no genetic modifications. The PFC samples were dissected from the anterior part of the superior frontal gyrus, a cortical region approximately corresponding to Brodmann area 10. All tissues were snap-frozen after dissection and stored at −80 °C without thawing. Total RNA was extracted by TRIzol (Invitrogen, USA) according to the manufacturer's instructions. All RNA quality was assessed using an Agilent 2100 Bioanalyzer. Only samples with RNA Integrity Number (RIN) values greater than or equal to 8 were used in this study. For the pooled sample, 4 μg total RNA from each of five individuals from the same species was merged into 20 μg pool sample.

Sequencing libraries were prepared as previously described ([@evw038-B14]). Briefly, 20 μg total RNA was purified by RNeasy MinElute Cleanup Kit (Qiagen, Germany). Ribosome RNA was then removed using the RiboMinus Eukaryote Kit (Ambion, USA). Purified RNA was loaded to a denaturing 15% TBE-PAGE (Tris-Borate-EDTA Polyacrylamide Gel Electrophoresis) gel (Invitrogen), and the range of the gel containing 100- to 200-nt-long RNA was extracted, ligated to the adapters, amplified, and sequenced following the Small RNA Sample Preparation Protocol (Illumina, USA).

Transcriptome Data Analysis
---------------------------

The pooled samples were sequenced with a read length of 36 bp, while the individual samples were sequenced on Illumina HiSeq 2000 with a read length of 50 bp. The reads were then mapped to a cumulative rRNA sequence constructed based on the rRNA gene sequences from SILVA and UCSC ([@evw038-B36]; [@evw038-B17]) databases. The mapping was performed by Bowtie2 with default parameters ([@evw038-B25]). Reads that mapped to rRNA were removed from further analyses. The remaining reads were mapped to the respective genome: Human, hg19; chimpanzee, panTro4; rhesus monkey, rheMac3; and mouse, mm10. Gene annotation was constructed using the human and mouse GENCODE annotation as a base (hg19: v19; mm10: m2) ([@evw038-B10]). We combined the two annotations using LiftOver, and searched for homologs of each exon in the chimpanzee and rhesus genomes ([@evw038-B17]).

The unique and multiple mapped read counts for each transcript were quantified with BEDtools ([@evw038-B37]). For multiple mapped reads, one genomic locus with the best alignment score was randomly selected. We further examined the reads proportion from different categories of transcripts, including snoRNAs, snRNAs, protein-coding transcripts, retained introns, other transcript types, and unannotated genomic regions. We used uniquely mapped reads for snoRNA expression quantification, and both uniquely and multiply mapped reads for snRNA expression quantification. Specifically, for each snRNA, including *U1*, *U2*, *U4*, *U5*, *U6*, *U7*, *U11*, *U12*, *U4atac*, and *U6atac*, we summed the read counts of all copies.

The snoRNA expression heatmap was constructed based on the log2-transformed RPKM (Reads Per Kilo bases per Million reads) values of snoRNA genes using R package "pheatmap." For each snoRNA gene, we conducted lineage analysis as follows: We used one-way Analysis of Variance (ANOVA) followed by Tukey's Honestly Significant Difference (HSD) test to calculate the significance of gene expression difference between each pair of species, and estimated the significance and the False Discovery Rate (FDR) by permutation of sample labels 100 times (permutation *P* \< 0.05, FDR \< 0.05). Based on their expression patterns, changes in snoRNA expression were assigned to ten groups: Human lineage (HL), chimpanzee lineage (CL), rhesus lineage (RL), mouse lineage (ML), human--chimpanzee shared lineage, human--rhesus shared lineage, human--mouse shared lineage, chimpanzee--rhesus shared lineage, chimpanzee--mouse shared lineage, and rhesus--mouse shared lineage. The expression changes assigned to a specific lineage should meet the following criteria: The expression in the corresponding species is significantly different from that in the other three species, and the expression distance to the average of all four species is the largest. The expression changes assigned to a shared lineage should show no expression difference between the two species sharing the lineage, but be significantly different from the expression level in the other two species. We further performed analysis using DESeq2 ([@evw038-B29]) to identify snoRNA differentially expressed among species. We then used the abovementioned procedure to assign observed changes to the lineages using the adjusted *P value* (P \< 0.05) and the normalized expression distance based on the size factor estimated by DESeq2. The expression analysis of snoRNA families was conducted using either uniquely mapped reads only or combing the uniquely and multiply mapped reads.

The assignment of the snoRNA to the corresponding family was carried out based on its Rfam ID, which was acquired from the Ensembl (Ensembl 78) annotation. The cumulative read counts for all snoRNA genes within a same family were used as the measure of snoRNA family expression. The heatmap construction, expression difference analysis, and the lineage assignment procedure were carried out using the same procedure as for individual snoRNAs.

To compare the transcriptional conservation of individual snoRNA genes with its family-level expression, we defined the dissimilarity value (1 − Rho, spearman's correlation coefficient) across species. The significance of this value's difference between the gene and family was estimated using a pairwise Wilcoxon test.

SnoRNA Sequence and Secondary Structure Analysis
------------------------------------------------

The alignment of snoRNA sequences was generated using the MUSCLE tool ([@evw038-B7]), with default parameters, from which we constructed a consensus sequence. The secondary structure of snoRNA was predicted and its minimum free energy (MFE) was calculated using the RNAfold tool from the Vienna RNA package2 ([@evw038-B28]). To evaluate the effect of human-specific mutations in the *SNORA29* sequence, we artificially mutated the *SNORA29* human--chimpanzee--rhesus consensus sequence using an identical number and type of nucleotide substitutions.

To clarify the role of mutation in snoRNA essential motif in regulating its expression, we investigated the occurrence of motifs in all the snoRNAs we analyzed. We searched the C box (\[AG\]UGAUGA), D box (CUGA), H box (ANANNA), and ACA box (ACA) for each snoRNA in each species. Meanwhile, the position and the order of two motifs had to be appropriate for eligible motif, such as the C box should be upstream of D box while the H box should be upstream of ACA box, as well as these motifs were not located within the stem of hairpin structure of snoRNA.

To determine whether secondary structure could influence the snoRNA abundance, we divided snoRNAs into four groups based on their expression in our data or in published data: Nonabundant or defined as not expressed (RPKM ≤ 2); low abundant (2 \< RPKM ≤ 50); medium abundant (50 \< RPKM ≤ 500), and highly abundant (RPKM \> 500). Subsequently, we compared the distribution of the minimal free energy normalized by length across these four groups, as well as compared these distributions to their corresponding genomic background using the Kolmogorov--Smirnnov test, and visualized the results using the R package "beanplot." The genomic background was derived from randomly selecting the genomic fragment with the same length distribution of corresponding snoRNAs and subsequently calculating the MFE for each fragment. The effect of MFE at the ribonuclear--protein complex level was investigated using public snoRNP abundance data from the PAR-CLIP experiments conducted for FBL, NOP56, and NOP58 components of C/D box snoRNPs, as well as DKC1 ([@evw038-B22]), the core protein of H/ACA snoRNAs.

The human and mouse intronic snoRNAs were determined by the intersection of genomic coordinates between introns and snoRNA genes using BEDtools. The Pearson correlation was calculated based on zero-mean-normalized, log-transformed snoRNA expression, host gene expression, and MFE values.

In Situ Hybridization
---------------------

The in situ hybridization was performed as described previously ([@evw038-B38]). In brief, the full length of *SNORA29* was cloned into the pGEM-T easy vector (Promega, USA). Digoxigenin (DIG)-labeled sense and antisense riboprobes were synthesized using SP6/T7 Transcription Kit (Roche, Switzerland) following manufacturer' instructions. The 14-μm thick brain tissue cryosections were mounted on positively charged slides, fixed with formaldehyde and acetylated. After prehybridization for 4 h, sections were hybridized overnight and washed in Saline Sodium Citrate (SSC) buffer six times. Alkaline phosphatase-conjugated anti-DIG antibody (Roche) was used to detect the hybridization signals, followed by development in buffer with NBT/BCIP for 16 h. Hybridization with the sense probe was performed in parallel and no signal was detected in all cases (data not shown). Immunohistochemical staining was performed after in situ hybridization. Developed sections were blocked with 10% normal goat serum and subsequently incubated with monoclonal anti-NeuN antibody (1:100, MAB377, EMD Millipore, USA).

Results
=======

We characterized the expression of transcripts with length between 100 and 200 nt in the frontal cortex of humans, chimpanzees, rhesus monkeys, and mice by sequencing the fraction of total RNA of the corresponding length. For each species RNA sequencing (RNA-seq) was conducted in three individual samples, as well as one pooled sample of five individuals ([supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online). This resulted in a total of 45,234,672 available sequence reads, 69.5% of which could be uniquely mapped to the corresponding genome ([supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online). Half of these reads mapped to annotated snRNA (1.3%) and snoRNA (52.9%). The remaining reads mapped to protein-coding transcripts (10.9%), retained introns (2.5%), other annotated transcript types (13.5%), and unannotated genomic regions (18.9%) ([fig. 1*A*](#evw038-F1){ref-type="fig"}). Allowing multiple mapping further increased the proportion of reads that mapped to snRNA genes, which are represented by multiple gene copies, to 11.4% ([fig. 1*A*](#evw038-F1){ref-type="fig"}). F[ig]{.smallcaps}. 1.---Expression of snRNA and snoRNA genes and families across four species. (*A*) Proportions of sequence reads in different transcript categories. (*B*) Expression of *U1* snRNA in four species. The species labels on this and the following panels: H, human; C, chimpanzee; R, rhesus monkey; M, mice. (*C*) Distribution of snoRNA gene expression changes on the evolutionary lineages (187 genes---total number of expressed snoRNA genes). (*D*) The expression dissimilarity value distribution of snoRNA genes and families for each pairwise species comparison (\**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001). (*E*) Expression of individual *SNORD116* genes. The colors indicate log2-transformed RPKM values. The labels of *SNORD116* genes showing human-specific expression are shown in red. (*F*) The cumulative expression level of *SNORD116* cluster. (*G*) Distribution of snoRNA family expression changes on the evolutionary lineages (134 families---total number of expressed snoRNA families).

Among the ten annotated snRNA families conserved across the four species, nine were expressed in our data (average RPKM ≥ 1) when allowing for multiple mapping ([@evw038-B11]). Expression of most snRNA was conserved among species ([supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online). The only exception was the expression of U1 snRNA: U1 expression was approximately 10-fold higher in the human brain compared with the brains of chimpanzees, macaques, and mice (Tukey-HSD test, *P* \< 0.05, FDR \< 0.05 after multiple testing correction) ([fig. 1*B*](#evw038-F1){ref-type="fig"}).

Of the 208 annotated snoRNA genes conserved across the 4 species, 183 were found to be expressed in our data (average RPKM ≥ 1) using uniquely mapped reads. In contrast to snRNAs, 83 (44%) were expressed differently among species (Tukey-HSD test, *P* \< 0.05, FDR \< 0.05 after multiple test correction). Assignment of these expression differences to evolutionary lineages resulted in 5 human-specific expression changes, 4 chimpanzee-specific ones, 12 changes assigned to the ape lineage, 13 to the macaque lineage, and 46 to the lineage connecting primates and mice ([fig. 1*C*](#evw038-F1){ref-type="fig"} and [supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online). Similar results were obtained using DESeq2 ([@evw038-B29]) ([supplementary fig. S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online), as well as considering male samples only ([supplementary fig. S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online).

Within a family, snoRNAs often share the same functionality ([@evw038-B12]). Thus, it has been suggested that changes in the expression of individual snoRNAs could be compensated for by expression changes of other snoRNAs from the same family ([@evw038-B18]). We indeed found substantially higher conservation of snoRNA expression at the family level compared with individual snoRNA ([fig. 1*D*](#evw038-F1){ref-type="fig"}).

*SNORD116* (*HBI-85*) snoRNA cluster can be used as an example of such conservation. The cluster is formed by tandem repeats, resulting in a snoRNA family cluster containing 29 members. Of these, 25 have detectable expression in our data. At the individual gene level these snoRNAs show substantial expression variation among species: Nine show significant lineage-specific expression changes among primates, including two on the human evolutionary lineage ([fig. 1*E*](#evw038-F1){ref-type="fig"}). In contrast, at the family level, *SNORD116* expression is completely conserved ([fig. 1*F*](#evw038-F1){ref-type="fig"}).

Species-specific changes in expression of snoRNA were nonetheless still observed after grouping snoRNA genes into families. Specifically, of the 134 snoRNA families expressed in brain, we identified 2 that showed expression change on the HL, 1 on the CL, 6 on the ape lineage, 6 on the macaque lineage, and 39 on the lineage connecting mouse and primates ([fig. 1*G*](#evw038-F1){ref-type="fig"} and [supplementary fig. S5](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online). Consistent results were obtained based on using both uniquely and multiply mapped reads ([supplementary fig. S6](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online).

Each of the two snoRNA families shows human-specific change containing only one member: *SNORA29* and *SNORA51*, respectively ([fig. 2*A*](#evw038-F2){ref-type="fig"}). Of the two snoRNAs, *SNORA29* expression changes much more drastically: While this snoRNA is highly expressed in mouse, macaque, and chimpanzee brains, its expression drops as much as 1,000-fold in the human brain compared with the average of the other three species ([fig. 2*B*](#evw038-F2){ref-type="fig"} and [supplementary fig. S7](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online). F[ig]{.smallcaps}. 2.---The human-specific expression pattern of *SNORA29* and the underlying genetic mechanism. (*A*) Expression of snoRNA families showing expression changes specific to human, chimpanzee, and rhesus evolutionary lineages. (*B*) Expression of *SNORA29* in four species. (*C*--*E*) Predicted *SNORA29* secondary structure in humans/Neanderthals, chimpanzees, and rhesus monkeys. Red arrows indicate human-specific mutations. (*F*) MFE of *SNORA29* in humans/Neanderthals (H/N), chimpanzees (*C*), and rhesus monkeys (R). The cumulative curve is based on MFE values of *SNORA29* mutants artificially constructed based on the *SNORA29* human--chimpanzee--rhesus consensus sequence. (*G*) The MFE distribution for all snoRNA annotated in the four species; all snoRNA expressed in at least one of the four species (RPKM \> 2), and the human genomic background. The vertical dashed red line shows MFE of human *SNORA29*.

Similar to many other snoRNAs, *SNORA29* has intronic localization: Its sequence resides within the fourth intron of the *TCP1* gene. We assessed the expression of the *TCP1* gene in the frontal cortex of adult humans, chimpanzees, macaques, and mice using a publicly available polyA-plus RNA-seq data set ([@evw038-B2]). There are no substantial differences in *TCP1* expression among the four species ([supplementary fig. S7](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online). Furthermore, expression of another snoRNA located within an intron of the *TCP1* gene, *SNORA20*, is also highly conserved ([supplementary fig. S7](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online). Thus, the drastic drop in the abundance level of *SNORA29* on the human linage cannot be explained by a change in expression of its host gene.

To assess *SNORA29* expression in human tissues other than brain, we analyzed *SNORA29* expression based on available public data: Direct RNA sequencing and PAR-Clip of snoRNP core proteins and AGO proteins in human HEK293 cell line. We only detected low expression of *SNORA29* (RPKM = 1.21) in one of the three data sets (AGO PAR-Clip), while expression of other snoRNAs was substantially higher. At the same time, *TCP1* expression in HEK293 cell line is relatively high (RPKM = 100). This further confirms that decreased expression of *SNORA29* on the HL cannot be explained by a change in expression of its host gene.

By comparing the human *SNORA29* sequence with the consensus sequence of its primate homologs, we identified two nucleotide changes: An A to G substitution at position 133, and a C to T substitution at position 5 ([fig. 2*C*--*E*](#evw038-F2){ref-type="fig"} and [supplementary fig. S8](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online). These changes affect a conserved snoRNA element, the ACA box, and the first stem, respectively, and substantially affect *SNORA29* secondary structure ([fig. 2*C*](#evw038-F2){ref-type="fig"}). Notably, the two human-specific mutations result in an unusually large increase in free energy of the *SNORA29* secondary structure, indicating a sharp reduction in its stability ([fig. 2*F* and *G*](#evw038-F2){ref-type="fig"}).

We hypothesized that the reduction in *SNORA29* secondary structure stability, rather than human-specific regulation of *SNORA29* expression, may result in its decreased abundance in the human brain. To test this, we investigated the general relationship between snoRNA structural stability and expression abundance. Indeed, the abundance of all 4,765 snoRNAs detected in our RNA-seq data in at least one species is negatively correlated with the minimal free energy of their secondary structure (*r* = −0.29, *P* \< 0.0001). This relationship between the minimal free energy and snoRNA expression abundance was also clearly observed in a comparison of snoRNA groups separated based on their expression level in brain tissue ([fig. 3*A*](#evw038-F3){ref-type="fig"}). Furthermore, the same relationship can be observed using another snoRNA expression data set: A combined PAR-CLIP data set containing abundance levels of 1532 C/D box and H/ACA box snoRNPs ([@evw038-B22]) ([fig. 3*B*](#evw038-F3){ref-type="fig"}). Notably, for intronic snoRNAs, the amplitude of the correlation between the expression abundance and the minimal free energy was comparable or greater than the correlation between the expression abundance and the host gene expression ([fig. 3*C* and *D*](#evw038-F3){ref-type="fig"}). Taken together, these observations suggested that the decreased abundance of *SNORA29* in the human brain might be caused by the decreased stability of its secondary structure. F[ig]{.smallcaps}. 3.---Relationship between snoRNA abundance and its structure stability. (*A* and *B*) Distributions of MFE of snoRNAs and their genetic background in four snoRNA expression level groups. The expression of snoRNAs was quantified based on our data (*A*) and published PAR-CLIP data (*B*). (*C* and *D*) The Pearson correlation between intronic snoRNA expression and its relative position within intron, host gene expression, and MFE in human (*C*) and mouse (*D*). \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001.

To get a more precise estimate of the evolutionary time during which the two mutations affecting *SNORA29* secondary structure stability occurred, we investigated the genomes of Neanderthals and Denisovans ([@evw038-B26]). In both genomes, the nucleotides in these two loci were identical to that of modern humans ([supplementary fig. S8](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evw038/-/DC1) online). Thus, the mutations must have occurred after the human/chimpanzee split approximately 8 Ma, but before the human/Neanderthal and Denisovan separation a bit more than 500,000 years ago ([@evw038-B34]).

*SNORA29* is not unique in carrying lineage-specific mutations. Based on snoRNA sequence alignment among 4 species, 3 out of 5 (60%) snoRNA showing expression change on the HL, 2 out of 4 (50%) on the CL, 8 out of 13 (61.5%) on the rhesus monkey lineage, and 49 out of 49 (100%) on the ML have species-specific base substitutions. Taken together, 35 of these 58 substitutions (60%) change snoRNA's MFE in direction corresponding with the direction of the expression change. Among all snoRNAs showing species-specific expression change, mutations occurring within the essential snoRNA motifs are only present in *SNORNA29*.

To gain insights into *SNORA29* functionality in the brain, we assessed its localization in prefrontal cortex tissue of humans and rhesus monkeys using in situ hybridization. As shown in [figure 4*A*](#evw038-F4){ref-type="fig"}, we observed strong hybridization signals concentrated at a small region within nuclei in macaque, but not in human brain tissue. Such localization is a common feature of snoRNAs and marks their location in the nucleolar region. Notably, the *SNORA29* signal was found in only a fraction of all nuclei. Using NeuN antibodies, which mark neuronal nuclei, we showed that *SNORA29* localization is restricted to neurons ([fig. 4](#evw038-F4){ref-type="fig"}B and *C*). F[ig]{.smallcaps}. 4.---In situ hybridization of *SNORA29*. (*A*) In situ hybridization with *SNORA29* antisense probe in human (upper panel) and macaque (middle and bottom panels) prefrontal cortex. Nuclei were stained with DAPI (4\',6-diamidino-2-phenylindole). A merged image showed that *SNORA29* localizes in nucleolus and is not detectable in human tissue. (*B*) In situ hybridization with *SNORA29* antisense probe in macaque prefrontal cortex. Nuclei were stained with DAPI. Neuronal nuclei were stained with anti-NeuN antibody. The merged image shows that *SNORA29* is expressed in neurons. (*C*) Counts of neural (NeuN+) and nonneural (NeuN−) cells with *SNORA29* probe and DAPI staining.

Discussion
==========

In this study, we estimated the evolutionary conservation of snRNA and snoRNA expression in a specific tissue, frontal neocortex, of four mammalian species including humans. Our customized sequencing strategy succeeded in capturing the expression of these two mid-size RNA classes, allowing us to determine expression level divergence of individual transcript and transcript families among the four species.

Surprisingly, despite the presumed conservation of snRNA and snoRNA functionality, we observe a substantial divergence of their expression levels among the four mammalian species used in our study. Furthermore, we find striking examples of snRNA and snoRNA expression level changes that have occurred within the past 6--8 Myr of human evolutionary history: *U1* snRNA showing approximately 10-fold higher expression, and *SNORA29* showing approximately 1,000-fold lower expression in human brain cortex compared with other species.

The case of elevated expression of *U1* in human brain stands out, as this is the only significant snRNA expression change detected in our study on any of the four evolutionary lineages. It is appealing to speculate that elevated human-specific expression of *U1* might be linked with additional roles played by this RNA in transcriptional regulation and RNA processing ([@evw038-B16]; [@evw038-B1]).

For snoRNAs expression, only moderate skew toward evolutionary acceleration on the human evolutionary lineage was observed: Five versus four snoRNAs show changes on the HL and CL at the gene level, two versus one at the family level. Still, the example of *SNORA29* snoRNA expression divergence on the HL is particularly striking. This snoRNA shows the same stable and high expression on the mouse, macaque, and chimpanzee evolutionary lineages that together covers approximately 110 Myr of conserved expression ([@evw038-B33]). Yet, this expression drops approximately 1,000-fold on the human evolutionary lineage, sometime between 8 and 0.5 Ma. Intriguingly, in contrast to other H/ACA snoRNAs that are known to guide pseudouridylation of rRNA and snRNA ([@evw038-B15]), *SNORA29* is an orphan snoRNA with no known targets ([@evw038-B27]). Our in situ experiments show no detectable *SNORA29* hybridization signal in human brain cortex, confirming the RNA-seq analysis results. The same experiments demonstrate that *SNORA29* expression is restricted to the nucleolus of neural cells in the macaque cortex, suggesting potential importance of this snoRNA to modulation of neuronal functionality. Intriguingly, in line with this notion, the *SNORA29* gene is localized within a chromosome region linked to schizophrenia ([@evw038-B6]; [@evw038-B35]). It has to be noted that these findings, although suggestive, certainly do not provide information about *SNORA29* role in evolution of human-specific cognitive features. Furthermore, *SNORA29* expression change is likely not to be restricted to brain. Still, a drastic decrease in *SNORA29* expression abundance on the HL after more than 110 Myr of conservatively high expression suggests contribution to the emergence of functional features unique to humans.

The *SNORA29* gene, similar to many other snoRNA genes, is located in the intron of a long mRNA transcript and has no independent promoter. Yet, we show that change in expression of *SNORA29* in human brain is not caused by host gene inactivation. Instead, our result suggests that *SNORA29* expression change is caused by two mutations, shared by humans and Neanderthals, which drastically destabilize the *SNORA29* secondary structure. Our further analysis of intronic snoRNA expression, conducted using our data set, as well as published data, shows that the minimal free energy of snoRNA's secondary structure is often a better predictor of snoRNA expression than the expression level of its host gene. This suggests that in the absence of their own promoters, changes in snoRNA secondary structure stability represent a major mechanism of independent snoRNA expression regulation ([fig. 5](#evw038-F5){ref-type="fig"}). F[ig]{.smallcaps}. 5.---Schematic representation of suggested abundance regulation mechanisms for mRNA and snoRNA.

Comparison of snoRNA expression among species shows substantially higher conservation at the family level than at the individual snoRNA level. This observation is compatible with the notion that changes in the expression of individual snoRNA are compensated by expression changes of other snoRNA from the same family ([@evw038-B18]). Still, we observe substantial snoRNA expression divergence among examined species both for snoRNA families and individual snoRNAs. Of the 187 snoRNA genes and 134 snoRNA families present in the four species and expressed in brain, 44% and 40%, respectively, show divergent expression among species. Such a high extent of expression-level divergence contradicts sharply the presumed conservation of snoRNA functionality.

As for other RNA types, such as mRNA, microRNA, or lncRNA ([@evw038-B4]; [@evw038-B31]; [@evw038-B32]), the extent of snoRNA expression divergence among species is largely proportional to the phylogenetic divergence. This might indicate that snoRNA expression divergence merely reflects the accumulation of genetic divergence among species and has no functional effect. This notion, however, is hardly compatible with the essential role played by snoRNA in the modification of highly conserved functional RNA molecules. Thus, the unexpectedly rapid pace of snoRNA expression evolution suggests that snoRNAs play a more dynamic role in the RNA-based regulatory and functional networks than is currently appreciated.
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